Griseofulvin Oral Suspension (Anhydrous)
Griseofulvin is a compounded formulation containing Griseofulvin, prepared by Mixlab for veterinary use. Available by prescription.
How to Give Anhydrous Oral Suspension
Oral Suspension (Anhydrous) is a liquid medication that does not contain water in its base. This might be an oil-based or other special base to help stabilize the medicine. It will look like a regular liquid medication, but often needs a good shake because the drug can settle. Here's how to give it:
- Shake well each time to mix the medication (5-10 seconds).
- Measure the dose using the syringe/dropper provided or one recommended by your vet. Insert the top of the oral syringe into the bottle adapter. Turn the bottle upside down and pull the plunger until the medicine reaches the volume required
- Hold your pet steady: a towel or helper can assist with squirmy pets.
- Administer the dose slowly into the side of the mouth. Allow small pauses if needed for swallowing.
- Raise the head slightly to help the medication go down and clean any spills with a little water or tissue.
- Praise your pet and offer a treat or water (unless advised against feeding right after).
- Clean the syringe with water immediately after use. Store the bottle as directed, out of sunlight.
- Consistency is key: Shake each time, measure accurately, and contact your vet if any issues arise.
The uses and pharmacology described below reflect the FDA-approved labeling for this active ingredient; your veterinarian determines whether and how they apply to your animal's treatment plan.
Veterinarians most commonly consider griseofulvin when a patient is presented with clinical signs of dermatophytosis, more commonly known as ringworm. It is frequently a point of discussion for managing infections caused by Microsporum or Trichophyton species that affect the skin, hair and claws. By targeting the cellular structure of the fungi, your veterinarian can manage the progression of the infection within the keratinized tissues of the body.At a pharmacological level, griseofulvin acts as a fungistatic agent by disrupting the fungal cell's mitotic spindle structure. It binds to the tubulin proteins necessary for the formation of microtubules, which arrests the process of cell division (metaphase). A unique characteristic of griseofulvin is its affinity for keratin; following administration, the medication is deposited in the precursor cells of the skin, hair and nails. As these tissues grow and differentiate, they carry the medication with them, creating a physiological barrier that is resistant to further fungal invasion. Because of this mechanism, the duration of use is often linked to the time required for healthy, uninfected tissue to completely replace the old. Your veterinarian will determine whether griseofulvin is appropriate based on your pet’s species, weight and the results of diagnostic testing.
Prescription only. Use only under the direction of a licensed veterinarian. This information is not a substitute for veterinary diagnosis, prescribing or monitoring. Compounded drugs are not approved by the FDA for safety or effectiveness.
Commonly observed effects of griseofulvin administration include gastrointestinal changes such as vomiting, diarrhea or a temporary decrease in appetite. In feline patients, a significant clinical consideration is the risk of bone marrow suppression, which can lead to decreased levels of white blood cells or platelets. Because of this, your veterinarian will monitor for signs of hematological health shifts, often through regular blood work. In some animals, owners may observe localized skin irritation or a heightened sensitivity to sunlight (photosensitivity) shortly after the medication is administered. If you observe significant lethargy, fever or signs of an allergic reaction such as hives, contact your veterinarian promptly.This medication is typically used with caution or avoided in patients with known liver impairment, as the liver is the primary site for the metabolic processing of griseofulvin. It is strictly avoided in pregnant animals because it is associated with significant teratogenic effects, meaning it can cause developmental abnormalities in the offspring. Before starting a protocol involving griseofulvin, ensure your veterinarian has a complete history of all other prescriptions and supplements your pet is receiving, as it may interact with anticoagulants or certain sedative agents. Your veterinarian is the right person to design a comprehensive monitoring plan and provide guidance on the necessary duration of use to ensure the management approach remains suitable for your pet's individual health status.
Yes. Griseofulvin is a prescription medication and can only be dispensed by a licensed pharmacy upon receipt of a valid authorization from a licensed veterinarian. Mixlab verifies all authorizations before any medication is prepared or sent to your home or clinic.
Yes. While griseofulvin is available in certain commercial formats, Mixlab can compound this medication into specialized strengths or alternative flavored dosage forms—such as oral liquids or treats—if your veterinarian determines a customized preparation better suits your pet's needs. The decision between a commercial and compounded product rests with the prescribing veterinarian.
Veterinarians discuss long-term use of griseofulvin because the medication must be incorporated into new hair and skin cells as they grow. Since the medication only stops the fungi from dividing rather than killing it instantly, the old, infected tissue must be completely grown out and replaced by healthy tissue that contains the medication.
Owners are often advised to administer griseofulvin with a high-fat meal, as fat significantly increases the absorption of the medication into the bloodstream. Your veterinarian will provide specific guidance on administration techniques to ensure the management approach is as appropriate as possible for your pet's condition.
